Freedom Foods Group Releases Letter to its Ineligible Shareholders

Freedom Foods Group Limited (ASX: FNP) provides a range of high-value added dairy-based protein ingredient solutions to its customers.

Today (i.e. 29th May 2019), the company has released a letter about the Entitlement Offer (announced on 23 May 2019), in which it has explained reasons to the ineligible shareholders as to why they will not be able to subscribe for New Shares under the Entitlement Offer.

Summary Of The Retail Entitlement Offer (Source: Company Reports)

The company believes that it would be unreasonable to make offers to shareholders in all countries in connection with the Retail Entitlement Offer due to legal limitations on making or extending an offer of New Shares in some countries.

In the letter, the company has advised that it will not be extending the Retail Entitlement Offer to the ineligible shareholders and these shareholders will not be able to subscribe for New Shares under the Retail Entitlement Offer.

Shareholders who are eligible to participate in the Retail Entitlement Offer (Eligible Retail Shareholders) are shareholders who:

  • are registered as holders of existing Freedom Foods shares as at the Record Date;

(b) were not invited to participate (other than as nominee in respect of other underlying holdings) in the Institutional Entitlement Offer and were not treated as ineligible institutional investors under the Institutional Offer;

(c) as at the Record Date, have a registered address in New Zealand or Australia;

(d) are not in the US and are not acting for the account or benefit of a person in the US; and

(e) are eligible under all applicable securities laws to receive an offer under the Retail Entitlement Offer without any requirement for a prospectus or offer document to be lodged or registered.

Today, the company has also confirmed that the Retail Offer Booklet and personalised Entitlement and Acceptance Form in connection with the accelerated pro-rata non-renounceable entitlement offer has been dispatched to Eligible Retail Shareholders.

The Offer Price of $4.80 per New Share under the Retail Entitlement Offer is the same price paid by institutional investors under the Institutional Entitlement Offer and the Placement. It is expected that the Retail Entitlement Offer will raise around $10.6 million.

The company has already raised around $54.9 million by completing the Institutional Entitlement Offer. The Retail Entitlement Offer is being made to Eligible Retail Shareholders on the basis of 1 New Share for every existing 18 Freedom Foods shares held as at the Record Date.

In the last six months, the share price of the company increased by 12.24% as on 28th May 2019.  At market close on 29th May 2019, the stock of the company was trading at a price of $5.410, down 1.636% during the day’s trade with a market capitalisation of ~$1.35 billion. Its 52 weeks high price stands at $7.000 and 52 weeks low price at $4.150, with an average volume of 297,378.


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report